Kiemer AK - Search Results

1

Metabolic implication of tigecycline as an efficacious second-line treatment for sorafenib-resistant hepatocellular carcinoma.

Meßner M, Schmitt S, Ardelt MA, Fröhlich T, Müller M, Pein H, Huber-Cantonati P, Ortler C, Koenig LM, Zobel L, Koeberle A, Arnold GJ, Rothenfußer S, Kiemer AK, Gerbes AL, Zischka H, Vollmar AM, Pachmayr J. Meßner M, et al. Among authors: kiemer ak. FASEB J. 2020 Sep;34(9):11860-11882. doi: 10.1096/fj.202001128R. Epub 2020 Jul 11. FASEB J. 2020. PMID: 32652772

2

Effects of different natriuretic peptides on nitric oxide synthesis in macrophages.

Kiemer AK, Vollmar AM. Kiemer AK, et al. Endocrinology. 1997 Oct;138(10):4282-90. doi: 10.1210/endo.138.10.5459. Endocrinology. 1997. PMID: 9322941

3

The triterpenoid quinonemethide pristimerin inhibits induction of inducible nitric oxide synthase in murine macrophages.

Dirsch VM, Kiemer AK, Wagner H, Vollmar AM. Dirsch VM, et al. Among authors: kiemer ak. Eur J Pharmacol. 1997 Oct 8;336(2-3):211-7. doi: 10.1016/s0014-2999(97)01245-4. Eur J Pharmacol. 1997. PMID: 9384235

4

Autocrine regulation of inducible nitric-oxide synthase in macrophages by atrial natriuretic peptide.

Kiemer AK, Vollmar AM. Kiemer AK, et al. J Biol Chem. 1998 May 29;273(22):13444-51. doi: 10.1074/jbc.273.22.13444. J Biol Chem. 1998. PMID: 9593677 Free article.

5

Effect of allicin and ajoene, two compounds of garlic, on inducible nitric oxide synthase.

Dirsch VM, Kiemer AK, Wagner H, Vollmar AM. Dirsch VM, et al. Among authors: kiemer ak. Atherosclerosis. 1998 Aug;139(2):333-9. doi: 10.1016/s0021-9150(98)00094-x. Atherosclerosis. 1998. PMID: 9712340

6

The guanylate cyclase-coupled natriuretic peptide receptor: a new target for prevention of cold ischemia-reperfusion damage of the rat liver.

Gerbes AL, Vollmar AM, Kiemer AK, Bilzer M. Gerbes AL, et al. Among authors: kiemer ak. Hepatology. 1998 Nov;28(5):1309-17. doi: 10.1002/hep.510280520. Hepatology. 1998. PMID: 9794916

7

cGMP-mediated inhibition of TNF-alpha production by the atrial natriuretic peptide in murine macrophages.

Kiemer AK, Hartung T, Vollmar AM. Kiemer AK, et al. J Immunol. 2000 Jul 1;165(1):175-81. doi: 10.4049/jimmunol.165.1.175. J Immunol. 2000. PMID: 10861050

8

Atrial natriuretic peptide reduces expression of TNF-alpha mRNA during reperfusion of the rat liver upon decreased activation of NF-kappaB and AP-1.

Kiemer AK, Vollmar AM, Bilzer M, Gerwig T, Gerbes AL. Kiemer AK, et al. J Hepatol. 2000 Aug;33(2):236-46. doi: 10.1016/s0168-8278(00)80364-5. J Hepatol. 2000. PMID: 10952241

9

Elevation of intracellular calcium levels contributes to the inhibition of nitric oxide production by atrial natriuretic peptide.

Kiemer AK, Vollmar AM. Kiemer AK, et al. Immunol Cell Biol. 2001 Feb;79(1):11-7. doi: 10.1046/j.1440-1711.2001.00969.x. Immunol Cell Biol. 2001. PMID: 11168617

10

Induction of L-arginine transport is inhibited by atrial natriuretic peptide: a peptide hormone as a novel regulator of inducible nitric-oxide synthase substrate availability.

Kiemer AK, Vollmar AM. Kiemer AK, et al. Mol Pharmacol. 2001 Sep;60(3):421-6. Mol Pharmacol. 2001. PMID: 11502871

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page